Acquiring Company
Merck Group
Acquired Company
HUB Organoids
Darmstadt
UtrechtManufacturingBiotechnologyHealth CarePharmaceuticalLife ScienceBiotechnologyDescription
Merck, a leading science and technology company, announced the closing of the transaction to acquire HUB Organoids Holding B.V. (HUB) following regulatory clearances and the fulfilment of other customary closing conditions. The acquisition, which closed on December 23, 2024, is a strategic step aligned with the company’s commitment to providing novel next-generation biology solutions to the life science industry, specifically by enabling wider access to HUB’s technology for more faster and more effective drug development. Terms of the deal were not disclosed.
Quick answer
Merck Group is acquiring HUB Organoids, announced January 6, 2025. Merck Group is based in Darmstadt, Hesse, Germany.
- How much did Merck Group pay for HUB Organoids?
- The deal value was not disclosed.
- What does Merck Group do?
- Merck, a leading science and technology company, operates across life science, healthcare and electronics.
- Where are Merck Group and HUB Organoids based?
- Merck Group is based in Darmstadt, Hesse, Germany. HUB Organoids is based in Utrecht, Utrecht, Netherlands.
- Who are the decision-makers at Merck Group?
- Fundz holds 2 contacts at Merck Group. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Life Science
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Eton Pharmaceuticals completes acquisition of Galzin® (zinc acetate) from Teva Pharmaceuticals USA, Inc. to advance treatment for Wilson Disease (January 5, 2025)
- Cycle Pharmaceuticals completes acquisition of Banner Life Sciences, LLC to expand MS product portfolio (January 13, 2025)
- Novo Holdings completes acquisition of Catalent, Inc. (December 18, 2024)
- Pan-Am Dental completes strategic acquisitions of JB Dental Lab and Avaneer Dental Studio, solidifying its position as a top 10 dental lab group (February 10, 2025)
- Fagron strengthens its leadership with the acquisition of Guinama in Spain (February 4, 2025)
- AbbVie completes acquisition of Nimble Therapeutics to expand its immunology pipeline (January 23, 2025)
Who to call at Merck Group, and when
When Merck Group changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Merck Group raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Merck Group, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Merck Group. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Merck Group makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired HUB Organoids?
HUB Organoids was acquired by Merck Group, based in Darmstadt. The deal was reported on January 7, 2025. Merck, a leading science and technology company, operates across life science, healthcare and electronics. Merck Group is privately held and operates in Manufacturing.
When did Merck Group acquire HUB Organoids?
Merck Group's acquisition of HUB Organoids was reported on January 7, 2025. Merck, a leading science and technology company, announced the closing of the transaction to acquire HUB Organoids Holding B.V. (HUB) following regulatory clearances and the fulfilment of other customary closing conditions. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does HUB Organoids do?
HUB Organoids Holding B.V. It is privately held, operating in Biotechnology, and is based in Utrecht.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.